Saulis Banionis, MD
Interventional Pain Medicine · Wellington, FLNPI 1871792135
Payments from drug & device makers
Across 27 payments — averaging $77.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$1K
- AbbVie$453
- Merz North America, Inc.$176
- Revance Therapeutics, Inc.$123
- Vertos Medical, Inc.$70
- Si-bone, Inc.$28
- plus $35 from 2 others
What the payments were for
- Travel & lodging$1,05751%
- Food & beverage$1,02749%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 10 | $1,199 |
| AbbVie(2 entities) | 9 | $453 |
| Merz North America, Inc. | 1 | $176 |
| Revance Therapeutics, Inc. | 2 | $123 |
| Vertos Medical, Inc. | 2 | $70 |
| Si-bone, Inc. | 1 | $28 |
| Camber Spine Technologies LLC | 1 | $24 |
| SPR Therapeutics, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$1,033
- BOTOX$133
How this compares
$2,084 in reported general payments places this provider in the 30th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 163 | $4,776 |
| Fentanyl | 34 | $4,270 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 26 | $4,259 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 130 | $3,832 |
| Gabapentin | 268 | $3,035 |
| Morphine Sulfate ErMorphine Sulfate | 72 | $2,649 |
| Tizanidine Hcl | 106 | $1,403 |
| Methocarbamol | 95 | $1,197 |
| Methadone Hcl | 24 | $1,166 |
| Metaxalone | 14 | $1,047 |
| Morphine Sulfate | 12 | $886 |
| Baclofen | 26 | $590 |
| Pregabalin | 54 | $560 |
| Tramadol Hcl | 72 | $360 |
| Duloxetine Hcl | 37 | $350 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Wellington
- Ajay AntonyGainesville$1.9M
- Louis RasoJupiter$1.6M
- Gilbert MbeoOrlando$1.4M
- George BesongOrange City$1.2M
- Gary KaoMiddleburg$1.1M
- Neil EllisTampa$1.1M
- Alexis RentaBoynton Beach$1.1M
- Michael EspositoVero Beach$1M
- Jose RiveraTampa$993K
- Nomen AzeemRiverview$691K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.